Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darrell M Wilson

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Pediatric Diabetes|November 22, 2017
Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescentsGregory P Forlenza, Dan Raghinaru, Faye Cameron, et al.
Plos One|November 13, 2020
Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCRFelipe de Jesus Cortez, David Gebhart, Peter V Robinson, et al.
Lancet (London, England)|July 1, 2011
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialDiane K Wherrett, Brian Bundy, Dorothy J Becker, et al.
Diabetes Care|February 2, 2023
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention StudyDarrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, et al.
Diabetes Care|July 18, 2018
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 DiabetesMichael J Haller, Desmond A Schatz, Jay S Skyler, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Consensus report of the coalition for clinical research-self-monitoring of blood glucoseDavid C Klonoff, Richard Bergenstal, Lawrence Blonde, et al.
The New England Journal of Medicine|September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes, William V Tamborlane, Roy W Beck, et al.
Diabetes Care|May 12, 2009
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Roy W Beck, Irl B Hirsch, et al.
Diabetes|April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J Haller, S Alice Long, J Lori Blanchfield, et al.
Diabetes Care|March 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled TrialWilliam E Russell, Brian N Bundy, Mark S Anderson, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Pediatric Diabetes|November 22, 2017
Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescentsGregory P Forlenza, Dan Raghinaru, Faye Cameron, et al.
Plos One|November 13, 2020
Sensitive detection of multiple islet autoantibodies in type 1 diabetes using small sample volumes by agglutination-PCRFelipe de Jesus Cortez, David Gebhart, Peter V Robinson, et al.
Lancet (London, England)|July 1, 2011
Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trialDiane K Wherrett, Brian Bundy, Dorothy J Becker, et al.
Diabetes Care|February 2, 2023
CGM Metrics Identify Dysglycemic States in Participants From the TrialNet Pathway to Prevention StudyDarrell M Wilson, Susan L Pietropaolo, Maria Acevedo-Calado, et al.
Diabetes Care|July 18, 2018
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 DiabetesMichael J Haller, Desmond A Schatz, Jay S Skyler, et al.
Journal of Diabetes Science and Technology|November 4, 2009
Consensus report of the coalition for clinical research-self-monitoring of blood glucoseDavid C Klonoff, Richard Bergenstal, Lawrence Blonde, et al.
The New England Journal of Medicine|September 10, 2008
Continuous glucose monitoring and intensive treatment of type 1 diabetes, William V Tamborlane, Roy W Beck, et al.
Diabetes Care|May 12, 2009
The effect of continuous glucose monitoring in well-controlled type 1 diabetes, Roy W Beck, Irl B Hirsch, et al.
Diabetes|April 11, 2019
Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA<sub>1c</sub>, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial DataMichael J Haller, S Alice Long, J Lori Blanchfield, et al.
Diabetes Care|March 15, 2023
Abatacept for Delay of Type 1 Diabetes Progression in Stage 1 Relatives at Risk: A Randomized, Double-Masked, Controlled TrialWilliam E Russell, Brian N Bundy, Mark S Anderson, et al.
Pageof 11